The NEXT Oncology Team

Dr. Anthony Tolcher

Anthony W. Tolcher MD, FRCPC, FACP

CEO & Founder, Director of Clinical Research
Dr. Anthony Tolcher
Anthony W. Tolcher MD, FRCPC, FACP

CEO & Founder, Director of Clinical Research

Dr. Anthony Tolcher is a medical oncologist and co-founder of NEXT. He is dedicated to the development of new anticancer agents for patients whose current cancer therapy is no longer working to benefit them and are looking for their next option that includes clinical trials of new agents and therapies. Dr. Tolcher is proud that at NEXT Oncology the team scours the world to bring the best new agents back to our patients and centers.

This is not a job for Dr. Tolcher, it is his passion.

Raghad Karim

Dr. Raghad Karim

Medical Oncologist, Clinical investigator
Raghad Karim
Dr. Raghad Karim

Medical Oncologist, Clinical investigator

Dr Karim has joined Next Oncology following her passion for finding better and nonconventional therapies for her cancer patients.

She had chosen to dedicate her efforts to help find and accelerate new cancer drugs which can impact clinical oncology practice and larger number of patients nationally and world wide.

She is a Board certified oncologist and Hematologist.

Aracely Cavazos

Aracely Cavazos, BBA

Vice President of Regulatory Affairs & Administration
Aracely Cavazos
Aracely Cavazos, BBA

Vice President of Regulatory Affairs & Administration

Aracely is responsible for the comprehensive management of all regulatory aspects of clinical studies from study start-up through study termination according to ICH guidelines, GCP and regulatory requirements.  She is also responsible for the development, negotiation and ongoing maintenance of clinical trial budgets.  Aracely oversees both the regulatory affairs team and the administrative staff for NEXT Oncology.

Aracely has worked for more than 20 years in Phase I oncology.  Her leadership has led to the implementation and refinement of departmental standards to establish more efficient processes across the organization. Her purpose and passion are to help make clinical trials available to all cancer patients.  She is dedicated to providing operational guidance, performance development, coaching and mentoring to her team.

Aracely received her Bachelor’s Degree in Business Administration from The University of Texas at Austin.  When not working, Aracely enjoys spending time with family and friends.

Brianne Kaiser

Brianne Kaiser, BS, MBA, MLS (ASCP)CM

Director of Laboratory Services & Tissue Procurement
Brianne Kaiser
Brianne Kaiser, BS, MBA, MLS (ASCP)CM

Director of Laboratory Services & Tissue Procurement

Brianne Kaiser, BS, MBA, MLS(ASCP)CMis the Director of Laboratory and Research Sample Procurement for NEXT Oncology and works with oncology patients to ensure that the laboratory samples that are collected for the Phase I trials are processed and handled accurately to ensure that the testing conducted on these samples provides sounds results and good data.  Brianne has worked for Dr. Anthony Tolcher for 15 years doing Phase I Oncology trials in San Antonio, Texas.

Brianne graduated from Texas A&M University in 2002 with a Bachelor of Science in Biomedical Sciences.  She continued her education at The University of Texas Health Science Center in San Antonio and graduated in 2004 with a Bachelor of Science in Clinical Laboratory Sciences.  In 2009, Brianne earned a Master of Business Administration from the University of Incarnate Word.  Brianne was awarded the San Antonio Business Journal’s 40 Under 40 Award in 2016.

Cathy Alvarez

Cathy Alvarez, BSBA

Director of Data Management
Cathy Alvarez
Cathy Alvarez, BSBA

Director of Data Management

Cathy is responsible for managing all clinical data management activities according to quality standards, ICH guidelines, GCP and regulatory requirements. She also oversees the data management team to ensure that the staffing and the operational aspects of the data management group are in line with both NEXT Oncology and industry requirements.

Cathy has worked in the Phase I oncology field for over 20 years.  Her purpose and passion are to help find a cure for cancer.  She is committed to being the type of person that adds value to the lives around her.

Cathy was awarded The San Antonio Business Journal’s 40 under 40 Award for outstanding young professionals under 40 years of age who have demonstrated excellence in business, leadership and community involvement in 2010.

Cathy received her Bachelor of Science in Business Administration from The University of the Incarnate Word with a focus on International Business.  She is currently enrolled in the MBA program at The University of the Incarnate Word with a focus on Data Analytics and anticipates graduating in December of 2018.

Cathy is a native of South Texas and when not working, she enjoys traveling and watching sports.

Gina Mangold

Gina Mangold, MBA

Executive Vice President & Chief Operating Officer
Gina Mangold
Gina Mangold, MBA

Executive Vice President & Chief Operating Officer

Gina Mangold is the ExecutiveVice President & Chief Operating Officer for NEXT Oncology.

She is responsible for the administration, budgeting and management of contracts and manages all aspects of intellectual property involving NEXT and all its sponsors. She also directly supervises all the non-physician directors as well as the administrative staff.

She graduated from Texas A&M University in 1990 with a B.S. degree in Biomedical Science and earned an MBA in Business/ Finance from in 1996 Our Lady of the Lake University. She has over 25 years of experience in the field of Oncology drug development, and has worked with most of the world’s pharmaceutical and biotech companies to assist in developing their agents for treatment in patients with cancer.

She formerly served 11 years as a co-founder of South Texas Accelerated Research Therapeutics, LLC (START) and as the company’s Chief Operating Officer. In addition to those responsibilities, she also was CEO for START Shanghai. Prior to her roles in administration, Gina spent six years in preclinical cancer research and three years focusing on Tamoxifen-resistant breast cancer models, in vivo and in vitro. She previously served as Director of Research Administration and Manager of Preclinical Operations for the Cancer Therapy and Research Center (CTRC) in San Antonio.

Jamie Mills

Jamie Mills, BS

Chief Information Officer
Jamie Mills
Jamie Mills, BS

Chief Information Officer

Jamie Mills brings more than 17 years of hands-on experience with information system design, information system implementation, and information system operations.  As the Director of IT Services, Jamie oversees the architecture and implementation of all operational and business support systems, security and governance policies that are used to operate and manage the business IT infrastructure. Additional responsibilities and roles include the design, implementation and operation of healthcare applications that assist physicians, and researchers with monitoring and development of patient treatment plans.
 
Jamie previously served as a Director of Information Technology for a San Antonio based healthcare provider.  As the director, Jamie had a wide range of responsibilities including design, implementation, and operation of both national and international healthcare clinics.
 
Since graduating from Southwest Texas State University in 2000, Jamie Mills has worked in many industries including government, retail, and healthcare technology.  Jamie holds a Bachelor of Science and has achieved several Information Technology industry certifications.
Kimberly Fuchs

Kimberly Fuchs, CPA

Chief Financial Officer
Kimberly Fuchs
Kimberly Fuchs, CPA

Chief Financial Officer

Kimberly Fuchs serves as the Chief Financial Officer of NEXT Oncology managing the financial operations of the company.  Kimberly received a Bachelor of Business Administration in Accounting and a Master of Science in Accounting from The University of Texas at San Antonio. Kimberly is also a Certified Public Accountant. Prior to joining NEXT Oncology, Kimberly has worked in the healthcare industry since 2011 as a Controller, Director of Finance, and Chief Financial Officer.

Leslie Smetzer

Leslie Smetzer, BSN, RN

Vice President of Clinical Operations
Leslie Smetzer
Leslie Smetzer, BSN, RN

Vice President of Clinical Operations

Leslie Smetzer is the Vice President of Clinical Operations at NEXT Oncology where she leads our nursing team in caring for our Phase I Oncology patients. Leslie works with our team to provide the most cutting-edge and compassionate care available. She believes that oncology clinical trials bring courage and hope to people and their families who are battling cancer. Leslie has been named one of the top 10 nurses in San Antonio by the San Antonio Express News and a Healthcare Hero by the San Antonio Business Journal. Leslie received her Bachelor’s in science in nursing from the University of Texas Health Science Center and has over 25 years of experience in oncology and Phase I nursing.

Dr. Theresa Mays

Theresa Mays, BS, PharmD, BCOP, FASHP

Vice President of Investigational Drug Services
Dr. Theresa Mays
Theresa Mays, BS, PharmD, BCOP, FASHP

Vice President of Investigational Drug Services

Dr. Theresa Mays is the Vice President of Investigational Drug Services and a founding member of NEXT Oncology.

Dr. Mays received her BS in Pharmacy and Pharm.D. degree from the University of Oklahoma. She completed a hematology / oncology pharmacy specialty residency at the South Texas Veterans Health Care System in San Antonio, Texas. She is a board-certified oncology pharmacist (BCOP) and is a Fellow of the American Society of Health-System Pharmacy (ASHP).

Dr. Mays has over 25 years of experience in the pharmacy profession and for the last 18 years has specialized in providing investigational drug services to cancer patients enrolling in Phase 1 clinical trials.

Dr. Mays serves as a pharmacy resource for our pharmaceutical sponsors. She can assist with the challenges of delivering the wide variety of dose levels required in Phase I clinical trials, including stability challenges for intravenous investigational products and alternate methods for infusion of investigational products to patients.

Dr. Mays served as a course content matter expert for the BCOP review course for fifteen years and presented the supportive care modules for over a decade. She has presented nationally and internationally on a variety of topics for oncology pharmacists. In addition, she has published several articles and book chapters.

In addition to Phase I Oncology, Dr. Mays is very interested in supportive care. Her pharmacy team provides supportive care recommendations for our patients to help them achieve the best possible quality of life during their time at NEXT Oncology.